Head-to-head · Cost-Efficiency Index
Vytora Health vs Rylo Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Vytora Health
Shoppers who want flat per-dose pricing with a named pharmacy and an optional brand-name fallback, 50 states.
Visit Vytora HealthRylo Health
Shoppers who want one flat all-in monthly rate that doesn't rise as the dose increases.
Visit Rylo HealthThe verdict
Vytora Health takes it, leading the Cost-Efficiency Index 76 to 75. Vytora Health (Wasef Health, PC) is a 50-state-plus-DC telehealth platform selling flat-rate compounded semaglutide and tirzepatide alongside retail-priced brand-name Mounjaro and Zepbound ($1,399/mo each). Rylo Health still earns a C — Shoppers who want one flat all-in monthly rate that doesn't rise as the dose increases.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Vytora Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Vytora Health | Rylo Health |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 75/100 |
| Semaglutide / mo | $179/mo (all doses, compounded) | $149/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $199/mo (all doses, 3-month plan, compounded) | $249/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,788 |
| Tirzepatide / yr (modeled) | $2,388 | $2,988 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #51 | #52 |
Vytora Health
76/100Where the value is
- Semaglutide pricing is genuinely flat across all doses, not a 'starting at' floor
- 50 states plus DC covered, with per-state video-vs-audio requirements disclosed rather than hidden
- Both compounded and retail brand-name (Mounjaro, Zepbound) options on one platform
The tradeoffs
- The site's own FAQ and pricing page disagree on the 1-month tirzepatide price ($199 vs $249) — get the number confirmed at checkout before assuming either figure
- Brand-name Mounjaro/Zepbound at $1,399/mo is essentially full retail
Rylo Health
75/100Where the value is
- Stated flat pricing regardless of dose — 'No surprise charges, no tiered pricing' — a genuine differentiator versus tiered competitors
- Medication, provider review, and shipping all stated as included in the quoted price with no add-ons found
- Names its physician group (Lone Star Virtual Health PLLC) and dispensing pharmacy (VialsRX, Houston TX) rather than leaving both anonymous
The tradeoffs
- The '$100/$160 First 20 rate' shown prominently on the homepage is limited to the first 20 signups only — most shoppers will pay the higher $149/$249 standard rate, and the promo framing can make the real price look lower than it is
- The advertised 'quarterly $349/$499' option's actual billing mechanics (one-time total vs. recurring monthly-under-commitment) could not be verified — the product pages that would clarify this render via JavaScript and returned no readable pricing text
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.